IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,985,951 | +527.5% | 807,136 | +210.1% | 0.01% | +500.0% |
| Q2 2023 | $4,938,176 | +7.7% | 260,315 | -12.0% | 0.00% | – |
| Q1 2023 | $4,586,757 | +104.4% | 295,729 | +133.9% | 0.00% | – |
| Q4 2022 | $2,244,470 | +272.2% | 126,449 | +17.1% | 0.00% | – |
| Q3 2022 | $603,000 | -6.1% | 107,964 | -34.4% | 0.00% | – |
| Q2 2022 | $642,000 | -54.9% | 164,518 | -36.3% | 0.00% | – |
| Q1 2022 | $1,422,000 | -79.3% | 258,231 | -68.0% | 0.00% | – |
| Q4 2021 | $6,870,000 | +9.2% | 806,222 | +11.3% | 0.00% | -100.0% |
| Q3 2021 | $6,294,000 | -3.7% | 724,283 | +17.2% | 0.00% | – |
| Q2 2021 | $6,534,000 | +384.4% | 618,171 | +635.1% | 0.00% | – |
| Q1 2021 | $1,349,000 | -15.9% | 84,098 | +142.3% | 0.00% | – |
| Q4 2020 | $1,604,000 | +159.1% | 34,710 | +97.2% | 0.00% | – |
| Q3 2020 | $619,000 | – | 17,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |